JAMA Neurology Author Interviews podcast

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

0:00
21:13
Retroceder 15 segundos
Avanzar 15 segundos

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.

Related Content:

Otros episodios de "JAMA Neurology Author Interviews"